(Q48560546)

12 February 2018

title

Tolerogenic strategies to halt or prevent type 1 diabetes. (English)

1 reference

12 February 2018

0 references

Cooke A

1

1 reference

12 February 2018

Phillips JM

series ordinal

2

1 reference

12 February 2018

Parish NM

series ordinal

3

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 September 2001

1 reference

12 February 2018

published in

Nature Immunology

1 reference

12 February 2018

volume

2

1 reference

12 February 2018

issue

9

1 reference

12 February 2018

page(s)

810-815

1 reference

12 February 2018

Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Regulation of encephalitogenic T cells with recombinant TCR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Immunologic Aspects of the Nonobese Diabetic (NOD) Mouse: Abnormalities of Cellular Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to beta cells in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Anti-α/β T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

The regulation of autoimmunity through CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

"Infectious" transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

21 January 2018

Infectious tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

In vitro cultivation of human islets from expanded ductal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Insulin-promoter-factor 1 is required for pancreas development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

Antigen‐driven tissue‐specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein‐induced experimental autoimmune encephalomyelitis in the SJL mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Interferon-gamma enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Thymus-dependent monoclonal antibody-induced protection from transferred diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD/Shi/Kbe mice by anti-MHC class I Kd monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

PHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

-Cell Neogenesis in an Animal Model of IDDM

1 reference

https://api.crossref.org/works/10.1038%2FNI0901-810

7 January 2021

Identifiers

DOI

10.1038/NI0901-810

1 reference

12 February 2018

1 reference

12 February 2018